The share price of iFlyHealth (2506 HK, also known as Xunfei Healthcare) has just hit all time high.

It closed at $149.8 yesterday, far above its December 2024 IPO price of $82.8. Turnover was large, with ~US$ 20m traded yesterday.

The surge is partly due to iFlyHealth’s admission into the “stock-connect” program (港股通).

China Merchants China Direct Investments (CMCDI, 133 HK) owns US$ 43m worth of listed iFlyHealth shares as at 31 December 2024, accounting for 5.2% of its total assets. Share price has been up 70% since year-end.

We urge CMCDI to sell its iFlytek shares upon the expiry of lockup period, and use the proceeds to buy back shares.

Contact us:

💬 WeChat ID: ASM_Argyle

💬 WhatsApp ID: +852 6317 6371

🖥️ UnlockValueChinaMerchants.com

📧 ChinaMerchants@asmhk.com


讯飞医疗 (2506 HK 的股价刚刚创下历史新高。

昨日收盘价为 149.8 美元,远高于其 2024 年 12 月的 IPO 发行价 82.8 美元。成交额巨大,昨日交易额约 2000 万美元。

此次股价飙升部分归因于讯飞医疗被纳入“港股通”。

招商局中国基金 (133 HK) 截至 2024 年 12 月 31 日持有 4300 万美元的科飞健康股票,占其总资产的 5.2%。自年终以来,股价已上涨 70%。

我们强烈建议招商局中国基金在锁定期(lock-up)结束后出售其持有的讯飞医疗股票,并将所得资金用于回购股票。

欢迎随时与我们联系:

💬 WeChat ID: ASM_Argyle

💬 WhatsApp ID: +852 6317 6371

🖥️ UnlockValueChinaMerchants.com

📧 ChinaMerchants@asmhk.com

Leave a comment